AI Insight
This study investigated how different drugs targeting cholinergic receptors, particularly the alpha-7 nicotinic acetylcholine receptor (a7 nAChR), affect visual signal detection in rats. Using a signal detection theory framework, researchers found that blocking a7 nAChRs with the antagonist MLA paradoxically improved perceptual sensitivity (d') in a dose-dependent manner, even under distracting conditions, while positive allosteric modulation and partial agonism of the same receptor impaired performance. Blocking all nicotinic receptors with mecamylamine severely disrupted performance, whereas the cholinesterase inhibitor galantamine modestly improved sensitivity only without distraction.
Why it matters
These findings suggest that the a7 nAChR plays a bidirectional and nuanced role in perceptual sensitivity, challenging the straightforward assumption that activating this receptor should improve cognition, which has important implications for the development of treatments for attention-related disorders such as ADHD or schizophrenia.
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Rationale Cholinergic signalling is critical for attentional control and signal detection, yet the contribution of specific acetylcholine receptor (AChR) subtypes remains poorly understood. Although the 7 nicotinic AChR (nAChR) holds promise as a target for cognition-enhancing therapy, clinical findings to date have been inconsistent. Objective To investigate the effects of putative cognitive enhancing drugs, including those targeting cholinergic transmission and 7 nAChRs on a visual signal detection task (SDT). Methods Male and female Sprague Dawley rats were trained on an SDT. Cholinergic transmission was probed systemically with nicotinic and muscarinic receptor antagonists (mecamylamine and scopolamine), a cholinesterase inhibitor (galantamine), an M4-AChR positive allosteric modulator (PAM; VU0467154), an 7 nAChR antagonist (MLA), an 7 nAChR PAM (CCMI), and an 7 nAChR partial agonist (SSR-180,711). Dopaminergic transmission was probed using the catechol-O-methyltransferase (COMT) inhibitor, tolcapone. A novel, trial-level signal detection theory-based generalised linear mixed-effects model (SDT-GLMM) was used to index response bias and perceptual sensitivity (d’), the latter reflecting subjects ability to discriminate signal from noise. Results Mecamylamine profoundly impaired SDT performance across all measures. Galantamine significantly improved d’ at moderate doses but not when a distractor was present. MLA uniquely produced dose-dependent improvements in d’ that were preserved under distraction. In contrast, positive allosteric modulation and agonism of 7 nAChRs impaired task performance. Scopolamine, VU0467154, and tolcapone had no consistent or interpretable effects on signal detection. Conclusions This work demonstrates that 7 nAChR modulation bidirectionally and dose-dependently regulates perceptual sensitivity, irrespective of attentional distraction. These findings have implications for targeted cognitive enhancement in disorders of attention.